Keegy United States

You are in Choose your city Change
Choose your region and city

* Weather information available.

Search
07 Jan

Ensemble Discovery initiates strategic alliance with Pfizer

Ensemble Discovery today announced the initiation of a strategic alliance with Pfizer Inc. to discover and develop drug candidates of a novel class against a number of high-value pharmaceutical targets. ...

Bury News-Med...ews Feed 16 hours ago

Physicians perform first implantation of leadless cardiac monitoring device for detecting arrhythmias

BIOTRONIK SE & Co. KG, the pioneer of wireless remote monitoring technologies and leading manufacturer of implantable cardiac devices, today announced the first implantations of BIOTRONIK’s new leadless cardiac monitoring device performed by a team of physicians led by Professor Dr. Ger...

Bury News-Med...ews Feed 16 hours ago

First Edition: January 6, 2010

Today's headlines detail Democrat's intraparty efforts to finalize a health reform bill and the key policy issues at the heart of those negotiations. ...


Oral cladribine to be the first oral disease-modifying multiple sclerosis therapy despite receiving RTF letter

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a recent "refuse to file" (RTF) letter issued by the Food and Drug Administration (FDA) regarding Merck Serono's oral cladribine has heightened the competition...

Bury News-Med...ews Feed 16 hours ago

Commercially prepared foods contain more calories than indicated in nutritional labeling, say researchers

With obesity rising markedly, reliance on the accuracy of food labeling is an important weight management strategy. Since people who are trying to reduce their weight are encouraged to choose meals labeled as "lower in calories" or "reduced-energy" in restaurants and supermark...


Agilent Technologies, Covaris sign co-marketing agreement to streamline next-generation sequencing experiments

Agilent Technologies, Inc. (NYSE:A) and Covaris Inc. today announced a co-marketing agreement in which Covaris S2 DNA shearing technology will be marketed with the Agilent SureSelect Target Enrichment System to streamline next-generation sequencing experiments. ...

Bury News-Med...ews Feed 18 hours ago

Receive news for News-Medical Ne...

Details for News-Medical Ne...

  • 51 on the rank from United States
  • 25771 indexed news

Keegybot at News-Medical Ne...

  • Updated every 1 hour
  • Last KeegyBot visit 1 hour

Traffic from News-Medical Ne...

  • 8 Users sent from Keegy